|
HSP90B3P expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.547000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.959400E-01 |
| Normal-vs-Stage2 |
1.959420E-01 |
| Normal-vs-Stage3 |
6.648800E-01 |
| Normal-vs-Stage4 |
7.183400E-01 |
| Stage1-vs-Stage2 |
5.627600E-01 |
| Stage1-vs-Stage3 |
9.027500E-02 |
| Stage1-vs-Stage4 |
3.294800E-01 |
| Stage2-vs-Stage3 |
6.435700E-02 |
| Stage2-vs-Stage4 |
2.428200E-01 |
| Stage3-vs-Stage4 |
9.481600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.145400E-01 |
| Normal-vs-AfricanAmerican |
7.404800E-01 |
| Normal-vs-Asian |
3.573600E-01 |
| Caucasian-vs-AfricanAmerican |
3.814000E-01 |
| Caucasian-vs-Asian |
3.996600E-01 |
| AfricanAmerican-vs-Asian |
2.520800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.012800E-01 |
| Normal-vs-Female |
9.288600E-01 |
| Male-vs-Female |
1.803810E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.681800E-01 |
| Normal-vs-Extreme_Weight |
2.974400E-01 |
| Normal-vs-Obese |
5.681200E-01 |
| Normal-vs-Extreme_Obese |
4.785800E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.533200E-01 |
| Normal_Weight-vs-Obese |
8.019600E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.164000E-01 |
| Extreme_Weight-vs-Obese |
4.367800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.039000E-01 |
| Obese-vs-Extreme_Obese |
6.247600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.161200E-01 |
| Normal-vs-Age(41-60Yrs) |
5.901800E-01 |
| Normal-vs-Age(61-80Yrs) |
2.555400E-01 |
| Normal-vs-Age(81-100Yrs) |
4.143200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.176200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.206300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.507230E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.716610E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.404400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.064600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.890780E-01 |
| Normal-VS-Type2 PRCC |
8.545000E-01 |
| Normal-VS-KIRP CIMP |
8.615000E-01 |
| Normal-VS-Unclassified PRCC |
6.683200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.484200E-02 |
| Type1 PRCC-VS-KIRP CIMP |
9.057700E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.346400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
7.319400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.471600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.966800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.094200E-01 |
| Normal-vs-N1 |
1.597230E-01 |
| Normal-vs-N2 |
2.384800E-01 |
| N0-vs-N1 |
5.760700E-03 |
| N0-vs-N2 |
8.958100E-03 |
| N1-vs-N2 |
6.161800E-01 |
|
|
